Open AccessLEVONORGESTREL INTRAUTERINE SYSTEM AND CERVICAL CANCER. CLINICAL DIFFICULTIES
Author(s) -
O. Yu. Kruk
Publication year - 2020
Publication title -
aktualʹnì pitannâ pedìatrìï, akušerstva ta gìnekologìï
Language(s) - English
Resource type - Journals
eISSN - 2415-301X
pISSN - 2411-4944
DOI - 10.11603/24116-4944.2019.2.10931
Subject(s) - levonorgestrel , medicine , cervical cancer , obstetrics , gynecology , vaginal bleeding , intrauterine device , family planning , cancer , population , pregnancy , research methodology , environmental health , biology , genetics
. In recent years, intrauterine systems releasing levonorgestrel became popular. They are a reliable and safe means of contraception. However, the hormonal effects of such systems sometimes mask the clinical manifestations of intercurrent diseases, including those manifested by irregular uterine bleeding.
Case Description: The emergence of diagnostic difficulties in the occurrence of cervical cancer in two women who used intrauterine systems releasing levonorgestrel.
Conclusion. Proper evaluation of irregular vaginal bleeding, including cervical cytology, is a prerequisite for all women who are carriers of intrauterine systems releasing levonorgestrel.